Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New supramolecular system presented for intracellular activation of therapeutic gold particles

Dec. 22, 2010

New ICAM-1/VCAM-1-targeting nanocarriers developed for ocular neovascularization therapies

Dec. 20, 2010

Adimab to collaborate with Lilly, Genentech and Human Genome Sciences

Dec. 17, 2010

Lundbeck, Zenobia and Vernalis to codevelop dardarin inhibitors

Dec. 17, 2010

Apexigen and Centocor to collaborate on antibody discovery

Dec. 13, 2010

Scientists convert human fibroblasts directly to multipotent hematopoietic progenitors

Nov. 30, 2010

Merrion and Rebel Pharma enter into feasibility and option agreement

Nov. 29, 2010

Compugen develops new platform to discover new members of protein families

Nov. 26, 2010

Covidian licenses drug delivery platform technology from UBC and CDRD

Nov. 26, 2010

Advanced Proteome Therapeutics enters agreement to advance its SLMT platform

Nov. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...